Global Medical Microbiology Testing Technologies Market Assessment and Key Insights Analyzed till 2024

Posted on 2018-05-01 by Mark Hub in Healthcare // 0 Comments

Albany, USA, 2018-May-01 — /EPR Network/ —Market Research Report Search Engine (MRRSE) recently announced the addition of a new research study to its comprehensive collection of research reports. The research report, titled “Medical Microbiology Testing Technologies Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” offers a detailed analysis of the market providing insights into the market dynamics that are expected to influence the overall market positively in the next few years. Furthermore, the product segmentation, drivers, barriers, key geographical segments, and the competitive scenario of the global Medical Microbiology Testing Technologies Market have been elaborated upon in the research report.

To Get Sample Report Click Here @ https://www.mrrse.com/sample/1907

Rapid identification of microorganisms in medical microbiology can be of great value for selection of ideal treatments for patients for infections caused by bacteria, viruses, fungus, mycobacterium, and parasites. It enables actual reduction from conventional broad spectrum antimicrobial agents to specific targeted antimicrobial therapy. The various advantages associated with medical microbiology testing technologies over conventional manual systems, such as automated microscopy and serological testing have been the primary growth drivers for the global medical microbiology testing technologies market. According to the research report, the global medical microbiology testing technologies market was valued at US$2.1 bn in 2015 and is expected to reach US$3.4 bn by the end of 2024. The global market is expected to expand at a CAGR of 5.4% between the forecast years of 2016 and 2024.

Need for Testing among Geriatrics to Drive Global Market

The various advantages of medical microbiology testing technologies are the introduction of automation in clinical microbiology. Prior to these technologies, the sector entirely depended on highly skilled manpower to receive, process, and interpret the outcomes from a wide variety of clinical specimens with limited aid from automation, which was subject to the risk of human error. Increasing outbreak of various diseases, rising incidence of infectious diseases, public-private investments in the field of life science research and increasing funding and research grants are the major factors driving growth of the market for medical microbiology testing technologies. Testing volumes on the whole are expected to increase by 10 to 15% every year for the next 20 years as number of geriatrics in need of health care continue to rise.

Depending on the type of technology used in the medical microbiology testing technologies market, medical microbiology testing technologies are segmented into microscope, serological tests, and cell culture. Although the industry is witnessing increasing use of automated medical microbiology testing technologies by many end users for clinical specimen testing, hospitals and diagnostic centers are still considered as the key revenue-generating segments. These are thus likely to continue the lead in the coming years. This is attributed to the changing perception of people as well as healthcare practitioners.

Read Comprehensive Overview of Report @ https://www.mrrse.com/microbiology-testing-technologies-market

Asia Pacific to Follow Europe’s Lead during Forecast Period

In terms of geography, Europe claimed the largest regional share for medical microbiology testing technologies in terms of revenue. However, during the forecast period, the market in Asia Pacific for medical microbiology testing technologies will exhibit the highest market growth at a CAGR of 7.3%. High conversion rate from traditional testing methods to new advanced testing technologies is the key factors projected to trigger the market growth in APAC. The Asia Pacific region is also expected to lead product development and adoption of newer technologies. Improving economic conditions leading to increased purchasing power, increasing awareness regarding the benefit of testing technologies, and the presence of a large pool of patients suffering from various chronic diseases, the market is expected to grow at a double digit rate.

The key players operating in the global medical microbiology testing technologies market are Agilent Technologies Inc., Becton, Dickinson & Company, Beckman Coulter Inc. (A Danaher Company) Biomerieux SA, Bio-Rad Laboratories Inc., and Roche Holding AG.

Enquire about this Report @ https://www.mrrse.com/enquiry/1907

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Matched content

Editor’s pick